A personalized ovulation monitoring system designed to help couples take control of fertility efforts and successfully conceive is slated to become commercially available in the second quarter of this year.
An exhibitor at CES 2018 in Las Vegas, Mira is a Bay Area-based company focused on applying technology and machine learning to fertility. Their new Mira Fertility system, which consists of specimen-sampling wands, a USB-powered palm-sized device and an accompanying app, is built around a home-use, fluorescent-based test. According to the company, the test provides 99 percent accuracy at detecting the Luteinizing hormone (LH) peak, which occurs before ovulation.
The system, which is FDA-registered, also utilizes quantitative hormone tracking and algorithm-optimized ovulation prediction to inform women when their body is ready to get pregnant, along with providing personalized health insights and automatic cycle tracking.
Mira Fertility is the first of Mira’s range of fertility devices; a series of tests designed to guide users from conceiving to pregnancy is currently in the works. For more information, visit the company’s website at miracare.com.